NCT04662801 - Weight Regain Treatment Post-Bariatric Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 5, 2021

Primary Completion Date

September 13, 2022

Study Completion Date

September 13, 2022

Conditions

Obesity, Overweight

Interventions

BEHAVIORAL

Behavioral Weight Loss (BWL)

All participants will receive twelve weeks of BWL treatment.

BEHAVIORAL

Early Responder: BWL continued

Participants categorized as experiencing early weight loss at the end of the first month of treatment will continue with BWL for the remainder of treatment.

COMBINATION_PRODUCT

Early Non-responder: BWL continued with medication added

Participants categorized as not experiencing early weight loss at the end of the first month of treatment will continue BWL plus a weight loss medication (Naltrexone Bupropion) for the remainder of treatment.

Trial Locations (1)

06511

Yale University, New Haven

All Listed Sponsors

collaborator

American Psychological Foundation

OTHER

lead

Yale University

OTHER